Bicyclol Alleviates Atherosclerosis by Manipulating Gut Microbiota-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bicyclol Alleviates Atherosclerosis by Manipulating Gut Microbiota

Published:2022-01-27 Issue:9 Volume:18 Page:2105021
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Li Xiao‐Lin¹,Cui Jin‐Jin²,Zheng Wen‐Sheng¹,Zhang Jin‐Lan¹,Li Rui¹,Ma Xiao‐Lei¹,Lin Miao¹,Guo Hui‐Hui¹,Li Cong¹,Yu Xiao‐You¹,Du Peng¹,Zhao Li‐Min¹,He Shuwang³,Lan Pei¹,Jiang Jian‐Dong¹²,Che Yongsheng²,Wang Lu‐Lu¹²^ORCID

Affiliation:

1. State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia Medica Chinese Academy of Medical Science and Peking Union Medical College Beijing 100050 China

2. Institute of Medicinal Biotechnology Chinese Academy of Medical Science and Peking Union Medical College Beijing 100050 China

3. College of Pharmacy Shandong University Beijing 250012 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202105021

Reference48 articles.

1. Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters

2. Host-Gut Microbiota Metabolic Interactions

3. The gut microbiome in atherosclerotic cardiovascular disease

4. Absence of Microbiota (Germ-Free Conditions) Accelerates the Atherosclerosis in ApoE-Deficient Mice Fed Standard Low Cholesterol Diet

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the gut microbiome on atherosclerosis;mLife;2024-04

2. Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota;Drugs;2024-01-24

3. Dengyinnaotong attenuates atherosclerotic lesions, gut dysbiosis and intestinal epithelial barrier impairment in the high fat diet-fed ApoE−/− mice;Journal of Ethnopharmacology;2024-01

4. Gut Microbiota and Vascular Diseases: An Update;Cardiovascular Innovations and Applications;2024

5. Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis;ACS Nano;2023-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3